Advancing a US Single-Payer Model for Cell and Gene Therapy

This Viewpoint discusses the status of regulatory approval and reimbursement for cell and gene therapies in Europe and the US.

Authors

Stacie B. Dusetzina (ORCID: https://orcid.org/0000-0002-3907-9196)
Audun Brendbekken

Institutions

University of Bergen (NO)
Vanderbilt University Medical Center (US)

Publication Details

Journal: JAMA Internal Medicine
Published: 2025-10-20
DOI: https://doi.org/10.1001/jamainternmed.2025.5058
Citations: 1
Primary Topic: Pharmaceutical Economics and Policy
Type: article
Field-Weighted Citation Impact: 3.13

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Advancing a US Single-Payer Model for Cell and Gene Therapy

Stacie B. Dusetzina, Audun Brendbekken

Oct 20, 2025

1 citations

JAMA Internal Medicine

Pharmaceutical Economics and Policy

3.13

article

Advancing a US Single-Payer Model for Cell and Gene Therapy

Stacie B. Dusetzina, Audun Brendbekken

October 20, 2025article en

1 citations

Abstract

This Viewpoint discusses the status of regulatory approval and reimbursement for cell and gene therapies in Europe and the US.

JAMA Internal MedicineVol. 185(12)

University of Bergen (NO), Vanderbilt University Medical Center (US)

Openalex Percentile: Top 6%

Pharmaceutical Economics and Policy

3.13

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Advancing a US Single-Payer Model for Cell and Gene Therapy — Stacie B. Dusetzina, Audun Brendbekken · JAMA Internal Medicine (2025) | TGRS Research Map | TGRS